Publications

GLYCEMIC VARIABILITY AND PREGNANCY
Riëlle Hoek-Hogchem, Sarah Bovenberg, Pim Dekker, Erwin Birnie, Henk Veeze, Hans J. Duvekot, Sander Galjaard, Henk-Jan Aanstoot

Effects of peri-conception and pregnancy glycemic variability on pregnancy and perinatal complications in type 1 diabetes: a pilot study. Exp Clin Endocrinol Diabetes. 2022 Mar 14. Online ahead of print
AVAILABILITY & REPORTING OF TECHNICAL SPECIFICATIONS OF C-PEPTIDE ASSAYS
Pim Dekker, Martine de Vries, Henk-Jan Aanstoot, Joost Groen

Which C-peptide assay do you use? Increasing need for describing C-peptide assay performance. Pediatr Endocrinol Diabetes Metab 2022; 28 (1): 101–103
DEPRESSION & HBA1C IN DIABETES
Magdalena Beran, Rutendo Muzambi, Anouk Geraets, Juan Rafael Albertorio-Diaz, Marcel C. Adriaanse, Marjolein M. Iversen, Andrzej Kokoszka, Giesje Nefs, Arie Nouwen, Frans Pouwer, Jörg W. Huber, Andreas Schmitt, Miranda T. Schram, for the European Depression in Diabetes (EDID) Research Consortium

The bidirectional longitudinal association between depressive symptoms and HbA1c: A systematic review and meta-analysis. Diabet Med . 2022 Feb;39(2):e14671.
DETECTION LIMITS OF C-PEPTIDE ASSAYS IN DIABETES RESEARCH
Kitty de Leur, Charlotte Vollenbrock, Pim Dekker, Martine de Vries, Erwin Birnie, Dick Mul, Bruce H. R. Wolffenbuttel, Joost Groen, Henk-Jan Aanstoot, Lianne Boesten

How low is really low? Comparison of two C-peptide assays to establish residual C-peptide production in type 1 diabetes. Diabet Med. 2022 Jan 6;e14785. Online ahead of print.
DEPRESSION & ANXIETY IN ADOLESCENTS WITH TYPE 1 DIABETES
Linh A. Nguyen, Frans Pouwer, Paul Lodder, Esther Hartman, Per Winterdijk, Henk-Jan Aanstoot, Giesje Nefs

Depression and anxiety in adolescents with type 1 diabetes and their parents. Pediatr Res . 2022 Jan;91(1):188-196.
CONSENSUS STATEMENT DO-IT-YOURSELF AUTOMATED INSULIN DELIVERY SYSTEMS
Katarina Braune, Rayhan A. Lal, Lenka Petruželková, Gary Scheiner, Per Winterdijk, Signe Schmidt, Linda Raimond, Korey K Hood, Michael C Riddell, Timothy Skinner, Klemens Raile, Sufyan Hussain on behalf of the OPEN International Healthcare Professional Network and OPEN Legal Advisory Group.

Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals. The Lancet Diabetes & Endocrinology, Epub ahead of print 13 Nov 2021
C-PEPTIDE AND IMPAIRED AWARENESS OF HYPOGLYCEMIA
Martine J Wellens, Charlotte E Vollenbrock, Pim Dekker, Lianne S M Boesten, Petronella H Geelhoed-Duijvestijn, Martine M C de Vries-Velraeds, Giesje Nefs, Bruce H R Wolffenbuttel , Henk-Jan Aanstoot, Peter R van Dijk

Residual C-peptide secretion and hypoglycemia awareness in people with type 1 diabetes. BMJ Open Diabetes Res Care . 2021 Sep;9(1):e002288.
MINDFULNESS & DIET QUALITY IN DIABETES
Shengxin Liu, Ivan Nyklíček, Frans Pouwer, Jane Speight, Mariska Bot, Giesje Nefs, Sabita S. Soedamah‑Muthu

Mindfulness in Relation to Diet Quality in Adults with Type 1 and Type 2 Diabetes: Results from Diabetes MILES‑The Netherlands. Mindfulness. 2021 Sep;12:2943–2954.
SEXUAL DYSFUNCTIONS IN DIABETES
Jolijn Van Cauwenberghe, Paul Enzlin, Giesje Nefs, Johannes Ruige, Christel Hendrieckx, Christophe De Block, Frans Pouwer

Prevalence of and risk factors for sexual dysfunctions in adults with type 1 or type 2 diabetes: Results from Diabetes MILES -Flanders. Diabet Med . 2022 Jan;39(1):e14676. Epub 2021 Sep 1.
HYPOGLYCEMIA & QUALITY OF LIFE IN ADOLESCENTS WITH TYPE 1 DIABETES
Manon Coolen, Jori Aalders, Melanie Broadley, Henk-Jan Aanstoot, Esther Hartman, Christel Hendrieckx, Giesje Nefs, Frans Pouwer

Hypoglycaemia and diabetes-specific quality of life in adolescents with type 1 diabetes. Diabet Med . 2021 Aug;38(8):e14565.
SWEET: BENCHMARKING TYPE 1 DIABETES CARE IN 19 COUNTRIES
Peter Gerhardsson, Anke Schwandt, Michael Witsch, Olga Kordonouri, Jannet Svensson, Gun Forsander, Tadej Battelino, Henk Veeze, Thomas Danne, on Behalf of the SWEET Study Group

The SWEET Project 10-Year Benchmarking in 19 Countries Worldwide Is Associated with Improved HbA1c and Increased Use of Diabetes Technology in Youth with Type 1 Diabetes. 2021 Jul;23(7):491-499.
DIAGNODE-2: RESULTS FROM TRIAL WITH DIABETES VACCINE DIAMYD® (GAD65-ALUM) PUBLISHED
Johnny Ludvigsson, Zdenek Sumnik, Terezie Pelikanova, et al. (including Theo Sas of Diabeter)

Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial. Diabetes Care . 2021 Jul;44(7):1604-1612.
REMOTE CARE IN COVID-19 TIMES
G Nefs, P Winterdijk, P Dekker, M De Vries, T Sas, D Mul, H Veeze, HJ Aanstoot

Transition to remote diabetes care in COVID-19 times: experiences from a specialized type 1 diabetes clinic. 14th International Conference on Advanced Technologies and Treatments for Diabetes, 2-5 June 202, online. Abstract: #359.
CLOSING THE LOOP: 780G SYSTEM
HJ Aanstoot, P Winterdijk, S Bovenberg, P Dekker, M De Vries, T Sas, D Mul, I Bliek, S Huijbers, M Alkemade, L Olierook, H Veeze

Effect of remote education in switching to a new advanced hybrid closed-loop system: improved time in range, sustained auto mode and better average glucose levels. 14th International Conference on Advanced Technologies and Treatments for Diabetes, 2-5 June 2021, online. Abstract: #319.
DUTCH NATIONAL DIABETES REGISTRY: DPARD
Jessica C. G. Bak, Dick Mul, Erik H. Serné, Harold W. de Valk, Theo C. J. Sas, Petronella H. Geelhoed-Duijvestijn, Mark H. H. Kramer, Max Nieuwdorp, Carianne L. Verheugt

DPARD: rationale, design and initial results from the Dutch national diabetes registry. BMC Endocr Disord. 2021 Jun 16;21(1):122.
MOOD/ANXIETY DISORDERS IN ADOLESCENTS WITH TYPE 1 DIABETES
Linh Anh Nguyen, Frans Pouwer, Per Winterdijk, Esther Hartman, Roos Nuboer, Theo Sas, Ineke de Kruijff, Willie Bakker-Van Waarde, Henk-Jan Aanstoot, Giesje Nefs

Prevalence and course of mood and anxiety disorders, and correlates of symptom severity in adolescents with type 1 diabetes: Results from diabetes LEAP. Pediatr Diabetes. 2021 Jun; 22(4):638-648.
TRANSFERRING RESPONSIBILITY FROM PARENTS TO CHILDREN IN TYPE 1 DIABETES
Jori Aalders , Esther Hartman, Frans Pouwer, Per Winterdijk, Edgar van Mil, Angelique Roeleveld-Versteegh, Elke Mommertz-Mestrum Henk-Jan Aanstoot, Giesje Nefs

The division and transfer of care responsibilities in paediatric type 1 diabetes: A qualitative study on parental perspectives. J Adv Nurs . 2021 Apr;77(4):1968-1979.
PRIMARY VS SECONDARY PATIENTS: THE DIABETER EXPERIENCE
P Dekker,D Mul, M De Vries, T Sas, HJ Aanstoot, H Veeze.

Glycaemic control in type 1 diabetes patients treated from clinical onset in a value-based care center vs. patients transferred from other centers: the DIABETER experience. 13th International Conference on Advanced Technologies and Treatments for Diabetes, 19-22 February 2020, Madrid. Abstract: #628.
REAL-WORLD DATA 670G HYBRID CLOSED-LOOP SYSTEM
Dick Mul, Arcelia Arrieta, Pim Dekker, Henk-Jan Aanstoot, Martine de Vries, Theo Sas, Henk Veeze

Increased time in range and sustained Auto Mode use in 670G hybrid closed-loop system users: real world experience in DIABETER. 13th International Conference on Advanced Technologies and Treatments for Diabetes, 19-22 February 2020, Madrid, Spain. Abstract: #170.
OPTIMIZING SCREENING OF LIPIDS IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES
Heyden JCV, Birnie E, Bovenberg SA, Dekker P, Veeze HJ, Mul D, Aanstoot HJ.

Losing Track of Lipids in Children and Adolescents with Type 1 Diabetes: Towards Individualized Patient Care. Exp Clin Endocrinol Diabetes. 2021 Jul;129(7):510-518.
THE QUALIMETER: IMPROVING DISCUSSIONS ON QUALITY OF LIFE
Donkers E, Dekker P, Winterdijk P, Mul D, Sas T, de Vries M, Veeze HJ, Aanstoot HJ, Nefs G, Eilander M.

The Qualimeter: Improving care for children and adults with type 1 diabetes by measuring and discussing Quality of Life. ICHOM 2019 conference.
EMOTIONAL PROBLEMS IN ADOLESCENTS WITH TYPE 1 DIABETES AND THEIR PARENTS/CAREGIVERS
Nefs G, Nguyen L, Winterdijk P, Hartman E, Sas T, Nuboer R, De Kruijff I, Bakker-van Waarde W, Aanstoot HJ, Pouwer F.

Study protocol of Diabetes LEAP: a Longitudinal study Examining emotional problems in Adolescents with type 1 diabetes and their Parents/caregivers. BMC Pediatr. 2019; 19: 377.
FRAMEWORK CONDITIONS FOR SUCCESFUL USE OF TECHNOLOGY IN TYPE 1 DIABETES
Mul D, Aanstoot HJ, Dekker P, de Vries M, Sas T, Veeze HJ.

Improvement of A1C can be obtained in an optimal and enabling setting that combines technology and patient-HCP contacts through data-upload and eHealth. 45th Annual of the International Society for Pediatric and Adolescent Diabetes (ISPAD), Oct 30-Nov 2 2019, Abstract: #O23
TO PUMP OR NOT TO PUMP: CSII DISCONTINUATION AMONG CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES
T Sas, C De Jong, M De Vries, P Dekker, HJ Aanstoot, H Veeze, D Mul.

Discontinuation of pump use in children and adolescents with type 1 diabetes. 12th International Conference on Advanced Technologies and Treatments for Diabetes, 20-23 February 2019, Berlin. Abstract: #279.
PEDIATRIC TYPE 1 DIABETES: A FAMILY DISEASE
Nieuwesteeg AM, Hartman EE, Aanstoot HJ, van Bakel HJ, Emons WH, van Mil E, Pouwer F.

The relationship between parenting stress and parent-child interaction with health outcomes in the youngest patients with type 1 diabetes (0-7 years). Eur J Pediatr. 2016;175:329-38.
CAROTID INTIMA MEDIA THICKNESS (CIMT) INCREASED IN PEOPLE WITH TYPE 1 DIABETES
Van der Heyden JC, Birnie E, Bovenberg SA, Cabezas MC, van der Meulen N, Mul D, Veeze HJ, Aanstoot HJ.

Do traditional cardiovascular risk factors solely explain intima-media thickening in youth with type 1 diabetes? J Diabetes Complications. 2016 Aug;30(6):1137-43.
SKIN AUTOFLUORESCENCE COULD BE EARLY SURROGATE MARKER FOR DIABETIC COMPLICATIONS
van der Heyden JC, Birnie E, Mul D, Bovenberg S, Veeze HJ, Aanstoot HJ.

Increased skin autofluorescence of children and adolescents with type 1 diabetes despite a well-controlled HbA1c: results from an observational cohort study. BMC Endocr Disord. 2016 Sep 9;16(1):49.
GADA PERSISTENCE AND DIABETES CLASSIFICATION
Ten Kate Q, Aanstoot HJ, Birnie E, Veeze H, Mul D.

GADA persistence and diabetes classification. Lancet Diabetes Endocrinol. 2016;4:563–564.
INCIDENCE OF PEDIATRIC TYPE 1 DIABETES DOUBLES IN 30 YEARS
Spaans EA, Gusdorf LM, Groenier KH, Brand PL, Veeze HJ, Reeser HM, Bilo HJ, Kleefstra N.

The incidence of type 1 diabetes is still increasing in the Netherlands, but has stabilised in children under five (Young DUDEs-1). Acta Pediatr. 2015;104:626-9.
DINO STUDY TO PROVIDE NEW INSIGHTS INTO PEDIATRIC TYPE 1 DIABETES
Eilander MM, de Wit M, Rotteveel J, Aanstoot HJ, Waarde WM, Houdijk EC, Luman M, Nuboer R, Oosterlaan J, Winterdijk P, Snoek FJ.

Diabetes IN development (DINO): the bio-psychosocial, family functioning and parental well-being of youth with type 1 diabetes: a longitudinal cohort study design. BMC Pediatrics. 2015;15:82.
GLOBAL STUDY COMPARES GLYCEMIC CONTROL RATES
McKnight JA, Wild SH, Lamb MJ, Cooper MN, Jones TW, Davis EA, Hofer S et al.

Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med. 2015;32:1036-50.
INSULIN DOSING CALCULATOR FOR PEOPLE WITH NEWLY DEVELOPED TYPE 1 DIABETES EVALUATED
Mul D, Aanstoot HJ, Simm D, Veeze HJ.

Initial insulin dosage in new onset pediatric diabetes: how to start? Presented at: 8th International Conference on Advanced Technologies and Treatments for Diabetes, 18-21 February 2015, Paris. Abstract: #286.
THYROID PEROXIDASE AUTOIMMUNITY IN TYPE 1 DIABETES – HOW PREVALENT IS IT?
D. Simm, E.Birnie, D. Mul, H.J. Veeze, H.J. Aanstoot.

Thyroid peroxidase autoimmunity and the effect on thyroid function in children and adolescents with type 1 diabetes. Presented at: 8th International Conference on Advanced Technologies and Treatments for Diabetes, 18-21 February 2015, Paris. Abstract: #376.
CAN SUBCLINICAL NERVE DYSFUNCTION BE DETECTED EARLY?
Van der Heyden J, van der Meer P, Birnie E, de Coo IF, Castro Cabezas M, Ozcan B, Veeze H, Visser GH, Aanstoot HJ, Blok JH.

Decreased excitability of the distal motor nerve of young patients with type 1 diabetes mellitus. Pediatr Diabetes. 2013;14:519-25.
QUESTIONNAIRE ASSESSES DIABETES-RELATED QOL
De Wit M, Winterdijk P, Aanstoot HJ, Anderson B, Danne T, Deeb L, Lange K, Nielsen AØ, Skovlund S, Peyrot M, Snoek F; DAWN Youth Advisory Board.

Assessing diabetes-related quality of life in youth with type 1 diabetes in routine clinical care: the MIND Youth Questionnaire (MY-Q). Pediatr Diabetes. 2012;13:638-46.
REVIEW ASSESSES IMPACT OF TYPE 1 DIABETES ON QUALITY OF LIFE
Nieuwesteeg A, Pouwer F, van der Kamp R, van Bakel H, Aanstoot HJ, Hartman E.

Quality of life of children with type 1 diabetes: a systematic review. Curr Diabetes Rev. 2012;8:434-43.
FAMILY FACTORS INFLUENCE PATIENT OUTCOMES
Cameron FJ, Skinner TC, de Beaufort CE, Hoey H, Swift PG, Aanstoot H, Aman J, Martul P et al.

Are family factors universally related to metabolic outcomes in adolescents with type 1 diabetes? Diabet Med. 2008;25:463-8.
© 2019 Diabeter | Terms of Use | Privacy Statement